USPTO 2015–2025 USPTO PatentsView US Corporation

Integrated DNA Technologies, Inc.

USPTO PatentsView assignee record - 70 granted patents across 24 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA).

Compiled by PlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

13.2

Avg claims per patent

+92%

5-year filing velocity

The verdict

Integrated holds 70 US patents across 24 technology areas, rank #4,952 of 50,000 tracked assignees.

#4,952
of 50,000 US assignees by volume: Top 12%
by Innovation Score (51.2/100): 13.2
avg claims per patent: +92%
filing velocity, last 5 yrs

Portfolio overview

Integrated DNA Technologies, Inc. has been granted 70 US utility patents between 2015 and 2025, placing Integrated DNA Technologies, Inc. at rank #4,952 across all assignees tracked by PlainPatent. This portfolio spans 24 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.2 claims per patent with primary concentration in C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA). As a US Corporation, Integrated DNA Technologies, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Integrated sits between Hermes Microvision Inc. (70 patents, rank #4,948) and Lantiq Beteiligungs-gmbh & Co. KG (70 patents, rank #4,956) - the closest US assignees by grant volume. The composite Innovation Score of 51.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 46 grants, compared with 24 in the 2015–2019 window, a +92% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Integrated DNA Technologies, Inc.'s 13.2 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 24 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Integrated DNA Technologies, Inc. against peers pursuing similar technology classes.

Hermes Microvision

70
Hi-lex

70
Hyundai Heavy Ind…

70
Industry-academia…

70
Intellectual Vent…

70
Johnson Health TE…

70
Krohne

70
Lantiq Beteiligun…

70
Integrated DNA ◀

70

What this shows Integrated holds 70 patents at rank #4,952, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Integrated

By rank, the assignees closest to #4,952 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Integrated's primary technology class.

Integrated's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

51 Top 12% higher than 88% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Integrated DNA Technologies, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	1.4%
2016	7	10.0%
2017	6	8.6%
2018	7	10.0%
2019	3	4.3%
2020	6	8.6%
2021	7	10.0%
2022	6	8.6%
2023	6	8.6%
2024	15	21.4%
2025	6	8.6%

Which technologies does Integrated DNA Technologies, Inc. patent most?

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 51

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 33

C12Y - ENZYMES 10

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 7

G16B - BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY 6

C12P - FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 6

C40B - COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES 6

C07K - PEPTIDES 6

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 4

B01J - CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS 3

G06F - ELECTRIC DIGITAL DATA PROCESSING 3

B01L - CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE 2

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 2

C07H - SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 2

G06N - COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS 2

Top 15 of 24 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Multi-domain

Claim Depth Standard

Velocity Accelerating

Where it ranks

Overall rank by patents

#4,952

Across all tracked assignees

Innovation Score

51.2 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Integrated DNA Technologies, Inc. hold?

Integrated DNA Technologies, Inc. holds 70 US granted patents filed between 2015 and 2025, spanning 24 technology areas.

What is Integrated DNA Technologies, Inc.'s Innovation Score?

Integrated DNA Technologies, Inc. has an Innovation Score of 51.2 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Integrated DNA Technologies, Inc. focus on?

Integrated DNA Technologies, Inc.'s top technology area is C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA) with 51 patents. The company has filed patents in 24 CPC subclasses total.

Is Integrated DNA Technologies, Inc.'s patent filing rate increasing or decreasing?

Integrated DNA Technologies, Inc.'s recent filing velocity is +92% compared to the prior five-year period. This indicates accelerating innovation.

What does claim depth mean for Integrated DNA Technologies, Inc.'s patents?

Integrated DNA Technologies, Inc.'s patents average 13.2 claims each. This falls within the standard range, providing solid legal coverage.

How is the Integrated DNA Technologies, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Integrated's 70 grants land it in the top 12% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Integrated ranks #4,952 of 50,000. Top 50 holders
Most of this portfolio concentrates in C12N - see who else leads that technology area. C12N leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.